Tylenol has been in the headlines for the last several weeks-though not for reasons any marketer would want. Despite a ...
The consumer healthcare company currently trades at about 15x earnings multiple, which represents a 9.41% undervaluation ...
Texas Attorney General Ken Paxton claims the makers of Tylenol failed to warn consumers of the risks. Here's who makes ...
Texas Attorney General Ken Paxton is suing the makers of Tylenol over allegedly deceptively marketing the over-the-counter ...
(Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, ...
The suit alleges that the Tylenol maker engaged in deceptive marketing by advertising the product as safe to use while ...
Renaissance Capital's bet on Kenvue is a bold one. The stock has performed poorly since the consumer health business spun off ...
The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, who accused ...
The company plans to name snack food executive Jon Halvorson as it faces a crisis over concerns of links between Tylenol and ...
Barchart on MSN
Do Wall Street Analysts Like Kenvue Stock?
Despite Kenvue’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a ...
Texas Attorney General Ken Paxton sues Kenvue and Johnson & Johnson over Tylenol’s alleged prenatal risks, citing autism and ...
Kenvue urged U.S. regulators to deny a request warning against Tylenol’s use during pregnancy, laying out the most detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results